Jagsonpal Pharmaceuticals Limited
JAGSNPHARM.NS - Insider Information
Get informed when a big investor buys or sells
+ FollowMarket Cap$14.29B
Close$
$410.13
89.7% upside
Current Fair Value
89.7% upsideUndervalued by 89.7% based on the discounted cash flow analysis.
Insider Trades
Loading insider trades…
Congress Trades
Loading congress trades…
Share Statistics
| Market cap | $14.29 Billion |
|---|---|
| Enterprise Value | $13.23 Billion |
| Annual dividend | $4.00 |
| Dividend yield | 1.85% |
| Earnings per Share | $6.4 |
| Beta | -0.35 |
| Outstanding Shares | 66,059,245 |
Return
| Return on Equity | 18.78% |
|---|---|
| Return on Assets | 14.20% |
| Return on Invested Capital | 21.42% |
Valuation & Multiples
| P/E Ratio | 31.9 |
|---|---|
| PEG | -1402.6 |
| Price to Sales | 4.6 |
| Price to Book Ratio | 6.0 |
| Enterprise Value to Revenue | 4.19 |
| Enterprise Value to EBIT | 23.38 |
| Enterprise Value to Net Income | 29 |
| Total Debt to Enterprise | 0.01 |
| Debt to Equity | 0.04 |
Revenue Sources
No data
Institutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
About Jagsonpal Pharmaceuticals Limited
1,297 employees
CEO: Manish Gupta
Jagsonpal Pharmaceuticals Limited specializes in the manufacturing and global supply of pharmaceutical products and active pharmaceutical ingredients (APIs). The company's primary therapeutic focus spans women's health, pain management, ...